Ella Hirani

958 total citations
27 papers, 775 citations indexed

About

Ella Hirani is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ella Hirani has authored 27 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cellular and Molecular Neuroscience, 14 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ella Hirani's work include Neuroscience and Neuropharmacology Research (14 papers), Neurotransmitter Receptor Influence on Behavior (13 papers) and Receptor Mechanisms and Signaling (7 papers). Ella Hirani is often cited by papers focused on Neuroscience and Neuropharmacology Research (14 papers), Neurotransmitter Receptor Influence on Behavior (13 papers) and Receptor Mechanisms and Signaling (7 papers). Ella Hirani collaborates with scholars based in United Kingdom, Spain and United States. Ella Hirani's co-authors include Susan P. Hume, Paul M. Grasby, Trevor Sharp, Victor W. Pike, Jolanta Opacka‐Juffry, Rabia Shabir Ahmad, Franziska Denk, L J Boothman, David J. Brooks and Safiye Osman and has published in prestigious journals such as NeuroImage, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Ella Hirani

27 papers receiving 756 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ella Hirani United Kingdom 17 499 285 161 123 109 27 775
Daniela Haeusler Austria 15 222 0.4× 133 0.5× 200 1.2× 230 1.9× 121 1.1× 35 760
Tibor Zelles Hungary 21 507 1.0× 502 1.8× 118 0.7× 185 1.5× 78 0.7× 53 1.2k
David Weinzimmer United States 19 384 0.8× 330 1.2× 151 0.9× 127 1.0× 106 1.0× 30 885
Marta Pazzagli Italy 15 480 1.0× 328 1.2× 85 0.5× 228 1.9× 76 0.7× 19 870
S. K. Luthra United Kingdom 14 302 0.6× 205 0.7× 253 1.6× 168 1.4× 80 0.7× 26 881
Saurav Shrestha United States 13 248 0.5× 156 0.5× 81 0.5× 117 1.0× 112 1.0× 20 627
Krista Fowles United States 12 188 0.4× 137 0.5× 81 0.5× 91 0.7× 50 0.5× 26 463
Per Stenkrona Sweden 18 205 0.4× 216 0.8× 119 0.7× 95 0.8× 128 1.2× 29 676
William Rea United States 19 636 1.3× 439 1.5× 263 1.6× 554 4.5× 93 0.9× 29 1.4k
Katrin C. Probst United Kingdom 8 684 1.4× 287 1.0× 79 0.5× 350 2.8× 62 0.6× 10 1.1k

Countries citing papers authored by Ella Hirani

Since Specialization
Citations

This map shows the geographic impact of Ella Hirani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ella Hirani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ella Hirani more than expected).

Fields of papers citing papers by Ella Hirani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ella Hirani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ella Hirani. The network helps show where Ella Hirani may publish in the future.

Co-authorship network of co-authors of Ella Hirani

This figure shows the co-authorship network connecting the top 25 collaborators of Ella Hirani. A scholar is included among the top collaborators of Ella Hirani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ella Hirani. Ella Hirani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lewis, Elise, Nathalie Fretellier, Paul A. Jones, et al.. (2023). Evaluation of gadolinium‐based contrast agents in pregnant CD‐1 mice and subsequent in utero exposure of the developing offspring, including behavioral evaluations. Birth Defects Research. 116(1). e2291–e2291. 3 indexed citations
2.
Lewis, Elise, Paul A. Jones, Nathalie Fretellier, et al.. (2023). Evaluation of gadolinium‐based contrast agents in juvenile CD‐1 mice including behavioral evaluations. Birth Defects Research. 116(1). e2284–e2284. 2 indexed citations
3.
Hellberg, Sanna, Johanna M. U. Silvola, Heidi Liljenbäck, et al.. (2019). Amyloid-Targeting PET Tracer [18F]Flutemetamol Accumulates in Atherosclerotic Plaques. Molecules. 24(6). 1072–1072. 9 indexed citations
4.
Jackson, Johanna, et al.. (2009). In vivo multimodal imaging of stem cell transplantation in a rodent model of Parkinson's disease. Journal of Neuroscience Methods. 183(2). 141–148. 21 indexed citations
5.
Egerton, Alice, Ella Hirani, Rabia Shabir Ahmad, et al.. (2009). Further evaluation of the carbon11‐labeled D2/3agonist PET radiotracer PHNO: Reproducibility in tracer characteristics and characterization of extrastriatal binding. Synapse. 64(4). 301–312. 16 indexed citations
6.
Brooks, David J., M Doder, S. Osman, et al.. (2008). Positron emission tomography analysis of [11C]KW‐6002 binding to human and rat adenosine A2Areceptors in the brain. Synapse. 62(9). 671–681. 45 indexed citations
7.
Egerton, Alice, Rabia Shabir Ahmad, Ella Hirani, & Paul M. Grasby. (2008). Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat. Psychopharmacology. 200(4). 487–496. 38 indexed citations
8.
Hume, Susan P., Anne Lingford‐Hughes, V. Nataf, et al.. (2007). Low Sensitivity of the Positron Emission Tomography Ligand [11C]Diprenorphine to Agonist Opiates. Journal of Pharmacology and Experimental Therapeutics. 322(2). 661–667. 23 indexed citations
9.
Boothman, L J, et al.. (2006). In vivo evidence that 5‐HT2C receptors inhibit 5‐HT neuronal activity via a GABAergic mechanism. British Journal of Pharmacology. 149(7). 861–869. 94 indexed citations
10.
Ahmad, Rabia Shabir, Ella Hirani, Paul M. Grasby, & Susan P. Hume. (2005). Effect of reduction in endogenous dopamine on extrastriatal binding of [11C]FLB 457 in rat brain—An ex vivo study. Synapse. 59(3). 162–172. 9 indexed citations
11.
Hirani, Ella, et al.. (2003). Effect of endogenous 5-HT on [C-11]MDL 100907 binding investigated in rat brain using PET. British Journal of Pharmacology. 138. 1 indexed citations
12.
Pike, Victor W., Christer Halldin, Kenji Nobuhara, et al.. (2003). Radioiodinated SB 207710 as a radioligand in vivo: imaging of brain 5-HT 4 receptors with SPET. European Journal of Nuclear Medicine and Molecular Imaging. 30(11). 1520–1528. 18 indexed citations
13.
Bantick, R. Alexander, Eugenii A. Rabiner, Ella Hirani, et al.. (2003). Occupancy of Agonist Drugs at the 5-HT1A Receptor. Neuropsychopharmacology. 29(5). 847–859. 41 indexed citations
14.
Houston, Gavin C., Susan P. Hume, Ella Hirani, Julian Goggi, & Paul M. Grasby. (2003). Temporal characterisation of amphetamine‐induced dopamine release assessed with [11C]raclopride in anaesthetised rodents. Synapse. 51(3). 206–212. 42 indexed citations
15.
Hirani, Ella, Jana Gillies, Akira Karasawa, et al.. (2001). Evaluation of [4‐Omethyl11C]KW‐6002 as a potential PET ligand for mapping central adenosine A2A receptors in rats. Synapse. 42(3). 164–176. 34 indexed citations
16.
Hume, Susan P., Ella Hirani, Jolanta Opacka‐Juffry, et al.. (2001). Effect of 5‐HT on binding of [11C] WAY 100635 to 5‐HT1A receptors in rat brain, assessed using in vivo microdialysis and PET after fenfluramine. Synapse. 41(2). 150–159. 76 indexed citations
17.
Hume, Susan P., Ella Hirani, Jolanta Opacka‐Juffry, et al.. (2000). Evaluation of [ O-methyl - 11 C]RS-15385-197 as a positron emission tomography radioligand for central α 2 -adrenoceptors. European Journal of Nuclear Medicine and Molecular Imaging. 27(5). 475–484. 19 indexed citations
18.
Hirani, Ella, Jolanta Opacka‐Juffry, Roger N. Gunn, et al.. (2000). Pindolol occupancy of 5-HT1A receptors measured in vivo using small animal positron emission tomography with carbon-11 labeled WAY 100635. Synapse. 36(4). 330–341. 42 indexed citations
19.
Opacka‐Juffry, Jolanta, Ella Hirani, Gerard R. Dawson, Sajinder K. Luthra, & S.P. Hume. (1999). Evaluation of [methyl-3H]L655,708 and [ethyl-3H]RY80 as putative PET ligands for central GABAA receptors containing α5 subunit. Nuclear Medicine and Biology. 26(7). 743–748. 5 indexed citations
20.
Pike, Victor W., Christer Halldin, Julie A. McCarron, et al.. (1998). [ carbonyl - 11 C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT 1A receptors in vitro and in vivo. European Journal of Nuclear Medicine and Molecular Imaging. 25(4). 338–346. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026